Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cybin Inc CYBN


Primary Symbol: N.CYBN

Healthcare Drug Manufacturers - Specialty & Generic
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary... see more

Bullboard (NEO:CYBN)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by Tardison Apr 08, 2024 8:40am

Globe says MindMed, Cybin get nod from U.S. FDA

2024-04-08 07:12 ET - In the News See In the News (C-MMED) Mind Medicine (MindMed) Inc (2) The Globe and Mail reports in its Monday edition that psychedelic drugs are making progress toward being ...more  
123
Post by Tardison Mar 19, 2024 2:57pm

Very Smart Money Bought In

Buy on any weakness IMO. This sector is and will continue to recieve serious attention. Cybin will be the belle of the ball IMHO. Tight Lines Gilly    Cybin closes $150-million (U.S ...more  
100
Post by Tardison Mar 18, 2024 7:51am

Cybin To Present

  Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas   2024-03-18 07:30 ET - News Release   ...more  
85
Post by Tardison Mar 15, 2024 8:34am

Phase 2 Proof Of Concept

https://ir.cybin.com/investors/news/news-details/2024/Cybin-Initiates-Phase-2-Proof-of-Concept-Study-of-CYB004-in-Generalized-Anxiety-Disorder/default.aspx Tight Lines  Gilly
54
Post by Tardison Mar 14, 2024 7:21pm

CYBIN CEO Doug Drysdale Interview

https://www.youtube.com/watch?v=qZWGF2M4vwE Tight Lines Gilly
80
Post by Tardison Mar 14, 2024 8:54am

News - Positive end of phase 2

https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Positive-End-of-Phase-2-Meeting-with-FDA-for-CYB003-in-Major-Depressive-Disorder-and-Phase-3-Program-Design/default.aspx Tight ...more  
57
Post by Tardison Mar 13, 2024 2:07pm

Market Taking The Big Raise Well

Just has to fill that small trading gap. https://ir.cybin.com/investors/news/news-details/2024/Announces-Oversubscribed-Private-Placement-of-U.S.-150-Million/default.aspx Still holding since Small ...more  
75
Post by BryceCanadaon Mar 07, 2024 6:58pm

Excellent coverage on CYBN!!

https://youtu.be/uW0vvAkSo18?si=efXVdd8f0bVqOrFV
80
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities